Clinical Trials Arena on MSN
IntraBio’s ataxia-telangiectasia drug meets endpoints in pivotal trial
If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.
As IntraBio works to grow the global treatment market for Aqneursa in Niemann-Pick disease type C, the company is already ...
Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.
Ataxia is a form of movement disorder. There is loss of balance and physical co-ordination leading to difficulty in walking normally. The Cerebellum of the brain is normally responsible for ...
Ataxia has no cure. There are no medications that can specifically treat and cure the symptoms of ataxias. However, medications may ease the symptoms by treating the underlying condition that causes ...
CHINO HILLS, Calif. (KABC) -- A Chino Hills family is living with a grim reality. Very few people know what Ataxia is. The neuro-degenerative condition runs in families, and the symptoms can start ...
GRAND RAPIDS, Mich. — Twenty years ago, Frederick Pepper, at 60 years old, knew something was wrong. After a misdiagnosis for vertigo, a doctor found what was causing Pepper's unbalance. "That doctor ...
Previously, the group investigated two models of dystonia, a different motor disorder, and demonstrated that preventing brainstem neurons from communicating with the cerebellum disturbed sleep. 4 ...
Research into Friedreich ataxia has been hampered by low availability of study participants. Now, a European consortium has released baseline data from a continuing study of 592 patients with ...
Friedreich ataxia (FA) is a rare, hereditary neurodegenerative disease that causes difficulties with coordination and balance and reduces lifespan. The disease affects approximately 1 in 50,000 people ...
IntraBio Inc. today announced positive topline results from its pivotal Phase III IB1001-303 clinical trial, "Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Randomized, ...
The NFL and NFL Players Association added a new set of criteria a player must meet to return to play under its new concussion protocol, barring any player exhibiting signs of ataxia from re-entering a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results